Grantham, Mayo, Van Otterloo & Co (GMO)’s Dillards DDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,128
Closed -$321K 595
2016
Q4
$321K Buy
5,128
+1,299
+34% +$85.3K ﹤0.01% 440
2016
Q3
$241K Sell
3,829
-40,377
-91% -$2.52M ﹤0.01% 456
2016
Q2
$2.68M Buy
44,206
+3,806
+9% +$248K 0.01% 343
2016
Q1
$3.43M Buy
40,400
+4,800
+13% +$360K 0.01% 331
2015
Q4
$2.34M Buy
35,600
+16,600
+87% +$1.34M 0.01% 323
2015
Q3
$1.66M Buy
+19,000
New +$1.84M 0.01% 348

Other funds holding DDS

Grantham, Mayo, Van Otterloo & Co (GMO)'s DDS Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Dillards (DDS) in Q1 2017, closing a stake of 5,128 shares — an estimated $321K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DDS in Q3 2015 and held it in 6 quarters. The position peaked at $3.43M in Q1 2016. 205 funds tracked by Wall St. Rank hold DDS as of Q1 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Dillards position as of Q1 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,128 Dillards shares in Q1 2017, an estimated $321K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Dillards in Q3 2015 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Dillards position peaked at $3.43M in Q1 2016.
  • 205 funds tracked by Wall St. Rank held Dillards as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.